Nancy J. Hutson, Director at PhaseBio Pharmaceuticals Inc (PHAS), bought 1,000 shares at $4.46 ($4K) on 2018-12-17, disclosed to the SEC on 2018-12-17.
Open-market purchase of $4k PHAS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |